Form 4 for WGS GeneDx Holdings Corp.
Accepted 2023-04-04 00:00:00 ET · period of report 2023-04-01 · accession 0001209191-23-023008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-04-01 | WGS | White Karen Ann | CHRO | M - OptEx | — | +3,276 | 55.4K | +6% | — |
| D | 2023-04-04 | 2023-04-03 | WGS | White Karen Ann | CHRO | S - Sale+OE | $0.34 | -1,731 | 53.7K | -3% | -$588.54 |
| D | 2023-04-04 | 2023-04-01 | WGS | White Karen Ann | CHRO | M - OptEx | $0.00 | -3,276 | 39.3K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-04-01 | M | A | 3,276 | — | 55,448 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Common | Class A Common Stock | 2023-04-03 | S | D | 1,731 | $0.34 | 53,717 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold as part of a block trade for multiple transactions at prices ranging from $0.3266 to $0.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 3 | Derivative | Restricted Stock Unit | 2023-04-01 | M | D | 3,276 | $0.00 | 39,312 | D | — · — to — | 3,276 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F4) 6.25% vest in quarterly installments over the 4-year period commencing on April 4, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date |